The pharma company said it believes there’s plenty of room for multiple industry players in the obesity drug market.

The startup will be headed by CEO Ron Renaud, who previously led Cerevel Therapeutics — a developer of drugs for neurological conditions — and oversaw its acquisition by AbbVie in an $8.7 billion deal ...

The media mogul has oft been the go-to girl for weight loss inspiration, tips, and tricks for years. So let's take a look at ...

Jon Gosselin had to "hit the gym" after running out of semaglutide. The 47-year-old reality star had been taking the ...

A MUM so overweight that her calf burst underneath now looks unrecognisable after she shed 10st without pills or surgery. Erin Drotleff began gaining weight in school, where classmates cruelly ...

FDA-authorized alternatives to brand-name weight loss medications gain traction, offering cheaper options for patients.

In a groundbreaking move, Eli Lilly (NYSE:LLY) is set to test its weight-loss medications on individuals who are not ...

Atlas Venture and Bain Capital Life Sciences are making their next bet in the buzzy obesity field, launching a new startup ...

Lizzo is being very vulnerable about her weight loss journey as she opens up about her struggles with overeating.

Fueled by the rise of the blockbuster GLP-1 drugs, including Ozempic and Wegovy, thinness appears to be making a comeback in ...

With early phase 1 data now out in the wild, metabolic disease outfit Metsera is wasting no time locking down supplies of its ...

A series of state and federal lawsuits challenging coverage exclusions for obesity drugs and procedures are testing the ...